In a major leap forward for medical technology, L&T Technology Services Limited (LTTS), a global leader in AI, digital, and R&D consulting, has announced the launch of its next-generation, AI-powered digital twin platform. Engineered specifically for lung navigation, surgical planning, and respiratory diagnostics, this innovative solution is set to redefine precision medicine.
By merging LTTS’s deep MedTech expertise in connected healthcare systems and AI-driven imaging with the sheer processing power of NVIDIA AI infrastructure, the platform promises to deliver unprecedented precision and vastly improved patient outcomes.
Redefining Medical Imaging and Anatomical Visualization
Traditionally, medical professionals have relied on static CT scans to plan complex procedures. The new LTTS lung digital twin solution disrupts this standard by integrating directly into existing CT imaging workflows. Using advanced deep learning models, the platform reconstructs a comprehensive, highly accurate 3D digital twin of the patient’s lungs.
This dynamic model redefines how clinicians visualize critical anatomical structures. Medical teams can now explore blood vessels, airways, lung lobes, and lesions in an immersive digital environment. This allows for highly accurate, patient-specific simulation of procedural pathways, which is especially critical for biopsy planning and bronchoscopy navigation.
Powered by Advanced NVIDIA AI Infrastructure
To achieve this level of real-time, high-fidelity simulation, the LTTS scalable digital twin platform is heavily fortified by NVIDIA’s Physical AI infrastructure. Key technological integrations include:
- NVIDIA Omniverse and OpenUSD: These tools drive the interactive 3D visualization of the lung anatomy, supporting the immersive exploration of highly complex biological structures.
- NVIDIA MONAI: This specialized framework enables advanced medical image segmentation, allowing the system to automatically identify and map tumors, vessels, airways, and distinct lung lobes.
- NVIDIA TensorRT: This technology optimizes AI inference performance, ensuring the system can process high-speed clinical workflows without lag.
By transforming static data into simulation-ready models, clinicians can significantly reduce pre-operative planning time while simultaneously elevating overall procedural safety.
Driving the Future of Precision Medicine
Leadership from both LTTS and NVIDIA emphasize the transformative potential of this collaboration for the global healthcare ecosystem.
“By combining LTTS’ engineering expertise in medical imaging and digital health platforms with the power of NVIDIA’s Physical AI infrastructure, we are enabling a new generation of AI-powered biological digital twins for precision medicine,” stated Amit Chadha, CEO & Managing Director of L&T Technology Services. “These platforms can transform how clinicians visualize lung anatomy, plan interventions, and deliver precision care.”
David Niewolny, Head of Business Development for Healthcare and Medical Technology at NVIDIA, echoed this sentiment: “Digital twins are emerging as a powerful new tool for precision medicine. By leveraging NVIDIA Physical AI infrastructure, Omniverse, MONAI, and TensorRT, LTTS is transforming CT data into interactive lung digital twins that allow clinicians to visualize anatomy in 3D, simulate procedures, and plan clinical interventions with greater confidence.”
As global rates of respiratory diseases such as COPD and lung cancer continue to rise, the demand for personalized, data-driven treatment pathways is accelerating. The integration of AI-driven digital twin technologies marks a vital shift away from traditional image interpretation and toward predictive, simulation-driven, and minimally invasive healthcare solutions.
Stay tuned to AarokaTech.com for the latest updates on B2B healthcare technology, AI infrastructure, and digital engineering innovations.
